• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: DEVICOR MEDICAL PRODUCTS, INC. HYDROMARK BREAST BIOPSY SITE MARKER; BIOPSY SITE IDENTIFIER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

DEVICOR MEDICAL PRODUCTS, INC. HYDROMARK BREAST BIOPSY SITE MARKER; BIOPSY SITE IDENTIFIER Back to Search Results
Model Number 4010-01-11-T3
Device Problem Patient Device Interaction Problem (4001)
Patient Problem Hypersensitivity/Allergic reaction (1907)
Event Date 08/28/2018
Event Type  Injury  
Manufacturer Narrative
The hydromark breast biopsy site marker is used to mark tissue during a percutaneous breast biopsy procedure, be visible under ultrasound for at least 6 week, and be permanently by x-ray and mri.The device has not been returned for evaluation, which prevents a full investigation and analysis of a root cause at this time.However, this failure mode has been identified in the risk management file for the effects of potential hypersensitivity with a potential for injury to the patient and/or user.Follow up medical intervention may be necessary.Although it could not be concluded that our device caused or contributed to this event, through evaluation by our medical advisor on similar events, this has been determined to be reportable pursuant to 21 cfr 803.
 
Event Description
Devicor medical products inc.Received a report from affiliate, devicor medical (b)(4), stating, "placement of the hydromark biopsy site marker was completed on (b)(6) 2018.Physician had confirmed before the operation that the patient was not allergic.Patient presented to the er later at that night with such allergy symptoms as decrease in blood pressure and urticaria.Physician thinks the occurence of the event may have caused by either anesthetic or hydromark".The patient was given loxoprofen by mouth for pain related to the biopsy.Update on august 30, 2018, upon physical exam , the physician confirmed the urticaria resolved.The cause of the reaction was determined to be the xylocaine used in the procedure, not the hydromark.This has been documented in our complaint system as report (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
HYDROMARK BREAST BIOPSY SITE MARKER
Type of Device
BIOPSY SITE IDENTIFIER
Manufacturer (Section D)
DEVICOR MEDICAL PRODUCTS, INC.
300 e. business way
fifth floor
cincinnati OH 45241
Manufacturer (Section G)
DEVICOR MEDICAL PRODUCTS DE MEDICAL
sor juana ines de la cruz
#20152 4-b, parque industrial
tijuana, baja california
Manufacturer Contact
shawna rose
300 e. business way
fifth floor
cincinnati, OH 45241
5138649178
MDR Report Key7899812
MDR Text Key121436992
Report Number3008492462-2018-00074
Device Sequence Number1
Product Code NEU
Combination Product (y/n)N
PMA/PMN Number
K121113
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign
Reporter Occupation Non-Healthcare Professional
Type of Report Initial
Report Date 08/28/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received09/21/2018
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number4010-01-11-T3
Device Catalogue Number4010-01-11-T3
Device Lot NumberUNKNOWN
Was Device Available for Evaluation? No
Date Manufacturer Received08/28/2018
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization;
-
-